Drug Delivery System Institute

The Drug Delivery System Institute is a Japanese biotechnology company specializing in the development of advanced drug delivery technologies, particularly polymeric micelle systems. The company focuses on enhancing the efficacy and reducing the toxicity of therapeutic agents by utilizing nanotechnology to ensure targeted delivery to specific tissues, such as tumors. Their research and development efforts span across various modalities, including small molecules and nucleic acids, aimed at addressing unmet needs in oncology and inflammatory diseases. By collaborating with pharmaceutical partners, the institute seeks to translate its proprietary delivery platforms into clinical-stage therapeutic candidates.